Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00424099 · ClinicalTrials.gov registry record · Phase 2
Methylphenidate and a Nursing Telephone Intervention for Fatigue
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 197
- Enrollment target
NCT00424099: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00424099 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 197 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00424099, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 197 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if methylphenidate (Ritalin) can help to control fatigue caused by cancer. Its effect on other symptoms such as drowsiness, depression, sleeplessness, physical activity, and anxiety will also be studied. Another goal of this study is to learn if receiving a phone call by a nurse improves fatigue in patients.
Interventions
- DRUG Placebo
- DRUG Methylphenidate
- BEHAVIORAL Nursing Telephone Intervention
- BEHAVIORAL Non NTI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2007-01-09 |
| Est. Completion | 2021-11-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00424099
The ClinicalTrials.gov registry entry for NCT00424099 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00424099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00424099 about?
NCT00424099 is a clinical study titled "Methylphenidate and a Nursing Telephone Intervention for Fatigue". The goal of this clinical research study is to learn if methylphenidate (Ritalin) can help to control fatigue caused by cancer. Its effect on other symptoms such as drowsiness, depression, sleeplessness, physical activity, and anxiety will also be studied. Another goal of this study is to learn if r...
What is the current status of trial NCT00424099?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 197 participants. The study started on 2007-01-09. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT00424099?
The interventions under investigation include: Placebo (DRUG), Methylphenidate (DRUG), Nursing Telephone Intervention (BEHAVIORAL), Non NTI (BEHAVIORAL).
Who is sponsoring clinical trial NCT00424099?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.